https://insilico.com/
Main | Insilico Medicine
Generative AI and Automation for Longevity and Sustainability
maininsilicomedicine
https://theorg.com/org/insilico-medicine
Insilico Medicine | The Org
insilico medicine
https://www.news-medical.net/news/20250225/Insilico-Medicine-reaches-preclinical-milestone-in-MASH-drug-discovery.aspx
Insilico Medicine reaches preclinical milestone in MASH drug discovery
Feb 25, 2025 - Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, recently achieved preclinical milestone...
insilico medicinereachespreclinicalmilestonemash
https://www.globenewswire.com/fr/news-release/2023/05/10/2665618/31533/en/AI-Drug-Discovery-Company-Insilico-Medicine-Offers-Free-Course-on-Target-Identification.html
AI Drug Discovery Company Insilico Medicine Offers Free
New York, May 10, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced today...
ai drug discoveryinsilico medicinecompanyoffersfree
https://www.news-medical.net/news/20231228/Insilico-Medicine-develops-new-AI-generated-FGFR23-inhibitor-for-tissue-agnostic-solid-tumors.aspx
Insilico Medicine develops new AI-generated FGFR2/3 inhibitor for tissue-agnostic solid tumors
Dec 28, 2023 - Insilico Medicine ("Insilico"), a generative artificial intelligence (AI)-driven clinical-stage drug discovery company, today announced the nomination of...
https://www.news-medical.net/news/20240119/Insilico-Medicine-leverages-AI-to-identify-promising-new-target-for-breast-and-gynecological-cancers.aspx
Insilico Medicine leverages AI to identify promising new target for breast and gynecological cancers
Jan 20, 2024 - Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven drug discovery company, recently published an early research...
https://www.prnewswire.com/news-releases/insilicos-rentosertib-inhalation-solution-receives-ind-clearance-for-the-worlds-first-ai-driven-candidate-to-enter-direct-to-lung-clinical-study-302755747.html
Insilico's Rentosertib Inhalation Solution Receives IND Clearance for the World's First AI-Driven...
Following positive Phase IIa results for oral Rentosertib in GENESIS-IPF with good tolerability, a favorable PK profile, and dose-dependent efficacy...
https://www.fiercebiotech.com/keyword/insilico-medicine
Insilico Medicine | Fierce Biotech
insilico medicinefiercebiotech
https://www.news-medical.net/news/20170405/Insilico-Medicine-announces-launch-of-intelligently-formulated-nutraceuticals-in-Europe.aspx
Insilico Medicine announces launch of intelligently-formulated nutraceuticals in Europe
Jun 19, 2019 - Insilico Medicine, Inc, a big data analytics company applying latest advances in deep learning to drug discovery, biomarker development, and aging research...
insilico medicineannounceslaunchintelligentlynutraceuticals
https://www.webthemez.com/tool/insilico
Insilico Review 2026: Pros and Cons, Pricing and Alternatives | WebThemez
Insilico review and guide: Learn features, pricing plans, use cases, and best alternatives for Research Based AI Tools.
pros and consreview 2026insilicopricingalternatives
https://insilico-soft.com/
Insilico | Agile Web Development Company
agile web developmentinsilicocompany
https://www.prnewswire.co.uk/news-releases/insilico-announces-successful-completion-of-phase-0-microdose-trial-and-initiates-phase-i-clinical-trial-for-its-first-ai-discovered-anti-fibrotic-product-candidate-with-novel-target-884919950.html
Insilico Announces Successful Completion of Phase 0 Microdose Trial and Initiates Phase I Clinical...
/PRNewswire/ -- Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that it has dosed...
https://keybase.io/erm_insilico
erm_insilico | Keybase
erm_insilico is now on Keybase, an open source app for encryption and cryptography.
erminsilicokeybase
https://www.news-medical.net/news/20180928/Insilico-Medicine-collaborates-with-MAWI-to-develop-multi-modal-biomarkers-of-aging.aspx
Insilico Medicine collaborates with MAWI to develop multi-modal biomarkers of aging
Jun 20, 2019 - Cardiovascular disease is the leading cause of death and disability in the world. On the eve of the annual World Heart Day, September 29th, Insilico Medicine,...
insilico medicineto develop
https://www.news-medical.net/news/20260410/Insilico-Medicine-launches-Pharma-AI-Spring-Kickoff-2026-webinar.aspx
Insilico Medicine launches Pharma AI Spring Kickoff 2026 webinar
Apr 10, 2026 - As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and...
insilico medicinepharma ailaunchesspringkickoff
https://www.prnewswire.co.uk/news-releases/insilico-medicine-initiates-first-in-human-study-of-ism001-055-a-novel-drug-discovered-using-insilico-s-proprietary-end-to-end-artificial-intelligence-platform-888138274.html
Insilico Medicine Initiates First-in-Human Study of ISM001-055, a Novel Drug Discovered Using...
/PRNewswire/ -- Insilico Medicine, an end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that the first healthy volunteer...
https://www.news-medical.net/news/20181130/Insilico-Medicine-to-present-work-on-AI-for-Drug-Discovery-at-the-AI-World-Conference.aspx
Insilico Medicine to present work on AI for Drug Discovery at the AI World Conference
Jun 19, 2019 - Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will...
ai for drug discovery
https://insilico.consulting/
InSilico Consulting AB
Bioinformatics and Data Science Consulting
insilicoconsultingab
https://informaconnect.com/lsx-world-congress/speakers/alex-zhavoronkov/
Alex Zhavoronkov - Insilico Medicine | LSX Europe Speaker
Join LSX Europe, the leading event for life science and healthcare leaders, in Lisbon, Portugal, on March 25-26, 2026. Designed for early to growth-stage...
alex zhavoronkovinsilico medicinelsxeuropespeaker
https://www.prnewswire.com/news-releases/insilico-medicine-announces-advancement-of-its-preclinical-candidate-for-usp1-synthetic-lethality-target-to-ind-enabling-studies-for-various-oncological-disorders-301524925.html
Insilico Medicine Announces Advancement of Its Preclinical Candidate for USP1 Synthetic Lethality...
/PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company today announced that...
insilico medicine
https://www.semafor.com/article/01/10/2024/insilico-wants-to-cure-disease-and-slow-aging-with-the-help-of-ai
Insilico wants to cure disease and slow aging, with the help of AI | Semafor
Insilico Medicine was one of the first to merge AI with drug discovery. CEO Alex Zhavoronkov now says advances could help extend human life.
https://informaconnect.com/lsx-world-congress/speakers/petrina-kamya/
Petrina Kamya - Insilico Medicine | LSX Europe Speaker
Join LSX Europe, the leading event for life science and healthcare leaders, in Lisbon, Portugal, on March 25-26, 2026. Designed for early to growth-stage...
insilico medicinepetrinakamyalsxeurope
https://www.deloitte.com/cn/en/about/press-room/deloitte-china-assists-listing-of-insilico-medicine-on-sehk.html
Deloitte China assists listing of InSilico Medicine on SEHK | Deloitte China
Deloitte China supported the listing of InSilico Medicine (InSilico Medicine, stock code: 03696.HK) on the Stock Exchange of Hong Kong (SEHK) on 30 December...
insilico medicinedeloittechinaassistslisting
https://hhai-insilico.vercel.app/
HHAI AI InSilico IND Predictor
aiinsilicoindpredictor
https://informaconnect.com/investival-showcase-usa/speakers/suguna-rachakonda/
Suguna Rachakonda - Insilico Medicine | LSX Investival Showcase USA Speaker
insilico medicinesugunarachakondalsxshowcase
https://www.prnewswire.co.uk/news-releases/menarini-group-and-insilico-medicine-enter-a-second-exclusive-global-license-agreement-for-an-ai-discovered-preclinical-asset-targeting-high-unmet-needs-in-oncology-302348075.html
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI...
This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform, similar to the...
https://prescience.in/
Prescience Insilico
Prescience insilico is a leading organization in drug discovery, high performance computing in material and life science domain
prescienceinsilico
https://www.news-medical.net/news/20181230/Insilico-to-present-AI-powered-end-to-end-pipelines-for-drug-discovery-at-Longevity-Therapeutics-2019.aspx
Insilico to present 'AI-powered end-to-end pipelines for drug discovery' at Longevity Therapeutics...
Dec 30, 2018 - Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will...
https://insilico-medicine-school.teachable.com/
Drug Target Identification | Insilico Medicine School
drug targetinsilico medicineidentificationschool
https://www.news-medical.net/news/20260324/Insilico-and-ASKA-partner-to-advance-AI-driven-gynecological-drug-discovery.aspx
Insilico and ASKA partner to advance AI-driven gynecological drug discovery
Mar 24, 2026 - Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced a...
ai driveninsilicoaskapartner
https://www.miragenews.com/insilico-unveils-selective-pkmyt1-inhibitors-1652762/
Insilico Unveils Selective PKMYT1 Inhibitors Breakthrough | Mirage News
Recently, the Insilico team's research entitled "An Internal Sulfur-Lone Pair Interaction Enabled the Discovery of Potential and Sub-Family Selective
insilicounveilsselectivepkmyt1inhibitors
https://www.news-medical.net/news/20181012/Insilico-to-present-advances-in-artificial-intelligence-at-the-Healthcare-Innovation-Summit-Africa-2018.aspx
Insilico to present advances in artificial intelligence at the Healthcare Innovation Summit Africa...
Jun 19, 2019 - Insilico Medicine, a Rockville-based leader in next-generation artificial intelligence for drug discovery, biomarker development, and aging research, is...
in artificial intelligence
https://gnqin.com/
GNQ Insilico
gnqinsilico
https://www.abdn.ac.uk/sbs/research/facilities-and-projects/sfirc/research/vaccine-development/parafishcontrol-pkd/
Insilico identification of candidate drug and vaccination targets in T. bryosalmonae | The School...
https://www.prnewswire.com/news-releases/insilico-medicine-earns-accolades-from-frost--sullivan-for-its-pioneering-rd-in-ai-for-aging-research-and-drug-discovery-300667607.html
Insilico Medicine Earns Accolades from Frost & Sullivan for Its Pioneering R&D in AI for Aging...
LONDON, June 19, 2018 /PRNewswire/ -- Based on its recent analysis of the North American market for artificial intelligence (AI) for aging research and drug...
https://ceposinsilico.de/
Cepos InSilico. Science for Scientists. Surface-faced modelling and simulation software.
Cepos InSilico's surface-based modelling techniques provide new in silico screening, modelling and simulation software designed to give accurate, generally...
modelling and simulationscience forceposinsilicoscientists
https://www.fiercebiotech.com/medtech/insilico-s-ai-networks-generate-custom-lead-compounds-for-fibrosis-less-than-50-days
Insilico's AI networks generate custom lead compounds for fibrosis in less than 50 days | Fierce...
Sep 4, 2019 - In the gold rush to bring artificial intelligence to the healthcare and biopharma industries, AI has long been pitched as a way to accelerate the pace of drug...
https://insilicobench.insilico.com/
Insilico Bench | Insilico Medicine
Insilico Bench - Proprietary AI Benchmarks for Drug Discovery. Comprehensive benchmarks for LLMs in clinical trial prediction and target discovery.
insilicobenchmedicine
https://www.capgemini.com/be-en/insights/expert-perspectives/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery/
Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery - Capgemini...
Sep 23, 2025 - Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery
insilico medicineai poweredcapgeminipartnering
https://www.livemint.com/companies/news/us-pharma-giant-eli-lilly-insilico-medicine-secure-deal-worth-2-75-billion-to-bring-ai-developed-drugs-to-market-11774807772029.html
US pharma giant Eli Lilly, Insilico Medicine secure deal worth $2.75 billion to bring AI-developed...
Mar 29, 2026 - US pharmaceutical giant Eli Lilly has reached a deal worth $2.75 billion with Insilico Medicine. Under the agreement, Lilly will bring AI-developed drugs to...
https://www.prnewswire.com/in/news-releases/insilico-medicine-appoints-dr-feng-ren-as-co-ceo-893437678.html
Insilico Medicine appoints Dr. Feng Ren as co-CEO
Dr. Feng Ren, Chief Scientific Officer (CSO) and head of global research and development is named co-CEO of Insilico Medicine Highlights: Insilico Medicine...
insilico medicineappointsdrfengren
https://www.prweb.com/releases/leading_computer_scientist_joins_insilico_medicine_s_war_on_aging_and_cancer/prweb11885423.htm
Leading Computer Scientist Joins InSilico Medicine's War on Aging and Cancer
Baltimore, Maryland (PRWEB) May 28, 2014 -- Today Insilico Medicine, Inc., a Deep Knowledge Ventures' portfolio company based in Baltimore, that is using...
war on agingcomputer scientistinsilico medicine
https://congratulationsoninsilicoipo.godaddysites.com/
Congratulations on Insilico IPO!
congratulationsinsilicoipo